Where it applies
Most commonly in hormone-receptor-positive breast cancer and in prostate cancer, where receptor status is established by pathology.
Hormone therapy
What it involves
Most commonly in hormone-receptor-positive breast cancer and in prostate cancer, where receptor status is established by pathology.
Testing on the tumour tissue determines whether hormone-directed treatment is relevant at all.
Hormone therapy is frequently continued for several years, and adherence over time has a real influence on outcome.
Effects vary by drug and may include hot flushes, joint or muscle symptoms, mood or sleep change, sexual health effects and fatigue.
Some hormone treatments affect bone density and metabolic parameters, so monitoring and preventive measures may be advised.
Ongoing review addresses tolerability, adherence, symptom management and surveillance alongside the rest of the follow-up plan.
Do not stop or change hormone therapy on your own. Side effects are often manageable, and stopping treatment early can affect outcomes; discuss any difficulty with your treating team.
Related